PDS Biotechnology Corporation Analysis
| Analyst Ratings |
|
Average Target Price
|
19.00
|
|
Average Rating
|
4.88
|
|
# Strong Buys
|
7
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.28
|
-0.26
|
0.02
|
7.14%
|
|
2022-06-30
|
-0.28
|
-0.20
|
0.08
|
28.57%
|
|
2022-03-31
|
-0.22
|
-0.32
|
-0.10
|
-45.45%
|
|
2021-12-31
|
-0.24
|
-0.22
|
0.02
|
8.33%
|
|
2021-09-30
|
-0.20
|
-0.24
|
-0.04
|
-20.00%
|
|
2021-06-30
|
-0.17
|
-0.03
|
0.14
|
82.35%
|
|
2021-03-31
|
-0.19
|
-0.14
|
0.05
|
26.32%
|
|
2020-12-31
|
-0.19
|
-0.18
|
0.01
|
5.26%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.78
|
|
2021-12-31
|
-0.63
|
|
2020-12-31
|
-0.99
|
|
2019-12-31
|
-1.22
|
|
2018-12-31
|
-23.99
|
|
2017-12-31
|
-33.60
|
|
2016-12-31
|
-1.35
|
|
2015-12-31
|
-7.38
|